Overactive Bladder - Results from #50

Therapeutic effectiveness and adverse drug reactions of mirabegron versus solifenacin in the treatment of overactive bladder syndrome. August 23, 2024

Biofeedback-Assisted pelvic floor muscle training combined with a short-duration drug regimen is safe and effective in women with overactive bladder: A randomized controlled trial. August 18, 2024

Device-Related Reoperations 8 Years Following Sacral Neuromodulation Implantation in Older Women. August 18, 2024

The relationship between dietary live microbe intake and overactive bladder among American adults: a cross-sectional study from NHANES 2007-2018. August 11, 2024

Intake of dietary flavonoids in relation to overactive bladder among U.S. adults: a nutritional strategy for improving urinary health. August 11, 2024

Barriers to Adherence to Overactive Bladder Treatment for Hispanic Women. August 11, 2024

The value of home-uroflowmetry in evaluation of voiding function in children with overactive bladder. August 11, 2024

Evaluation of transurethral GreenLight laser-selective vaporization for refractory overactive bladder in women. August 11, 2024

The Association of Adverse Pregnancy Outcomes With Overactive Bladder Anticholinergics. August 11, 2024

Isolated bladder training or in combination with other therapies to improve overactive bladder symptoms: a systematic review and meta-analysis of randomized controlled trials. August 9, 2024

Cost Analysis of Oral Phenazopyridine vs Intravesical Lidocaine for Preprocedural Analgesia for Intradetrusor OnabotulinumtoxinA Injections August 7, 2024

Effects of vaccination against COVID-19 on overactive bladder symptoms on young population. August 2, 2024

Immediate and continued results of parasacral transcutaneous electrical nerve stimulation in paediatric patients with overactive bladders. August 2, 2024

Efficacy and Safety of Combination Therapy With Vaginal and Urethral Erbium-Doped Yttrium-Aluminum-Garnet (Er:YAG) Laser for Overactive Bladder With Urinary Incontinence. August 2, 2024

Sacral Magnetic Neuromodulation with Intermittent Theta Burst Waveform Enhances Overactive Bladder: In Vivo Study. August 2, 2024

Deprescribing as a Way to Reduce Inappropriate Use of Drugs for Overactive Bladder in Primary Care (DROP): Protocol for a Cluster Randomized Controlled Trial With an Embedded Explanatory Sequential Mixed Methods Study. July 26, 2024

The association between different levels of depression and overactive bladder: A cross-sectional study of the 2005-2018 National Health and Nutrition Examination Survey. July 26, 2024

Sociodemographic Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries with Overactive Bladder in the United States. July 26, 2024

Review of the Impact and Burden of Urinary Urgency on Adults with Overactive Bladder July 25, 2024

Comparative analysis of real-world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study. July 25, 2024

Page 3 of 122